title: Disseminated histoplasmosis and human immunodeficiency virus type 1 infection: risk factors in Guatemala.
authors.forename: L
authors.initials: L
authors.lastname: Segura
authors.forename: M
authors.initials: M
authors.lastname: Rojas
authors.forename: N
authors.initials: N
authors.lastname: Pelaez
authors.forename: G
authors.initials: G
authors.lastname: Shor-Posner
authors.forename: D
authors.initials: D
authors.lastname: RosaRe
authors.forename: J
authors.initials: J
authors.lastname: Moreno
authors.forename: W
authors.initials: W
authors.lastname: Klaskala
authors.forename: M K
authors.initials: MK
authors.lastname: Baum
mesh_terms: D017088:AIDS-Related Opportunistic Infections / Q000175:diagnosis / Q000453:epidemiology; D000293:Adolescent; D000328:Adult; D000666:Amphotericin B / Q000627:therapeutic use; D000935:Antifungal Agents / Q000627:therapeutic use; D003695:Delivery of Health Care; D004358:Drug Therapy / Q000191:economics; D006166:Guatemala / Q000453:epidemiology; D015658:HIV Infections / Q000150:complications*; D015497:HIV-1; D006660:Histoplasmosis / Q000175:diagnosis / Q000188:drug therapy / Q000453:epidemiology*; D006801:Humans; D017964:Itraconazole / Q000627:therapeutic use; D008297:Male; D012189:Retrospective Studies; D012307:Risk Factors
chemical_list: D000935:Antifungal Agents; D017964:Itraconazole; D000666:Amphotericin B